The smaller decrease of eGFR in the PTX group with respect to the control group showed a trend at 6 months and reached statistical significance after 1 year, suggesting that a longer duration of treatment with PTX is necessary to observe a therapeutic benefit on renal function.
← all excerpts
Pentoxifylline for Renal Protection in Diabetic Kidney Disease. A Model of Old Drugs for New Horizons.
1
—
—